Byung Hyun Choi

Title: Byung Hyun Choi: Innovator in Protein Engineering and Cancer Treatment

Introduction

Byung Hyun Choi is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the fields of protein engineering and cancer treatment, holding a total of five patents. His innovative work focuses on developing methods and compositions that have the potential for commercial applications in biotechnology and pharmaceuticals.

Latest Patents

One of his latest patents is titled "Method for producing dual function proteins and its derivatives." This method involves the production of a biologically active protein alongside an FGF21 mutant protein. The technique allows for the stable production of the target protein by effectively preventing its decomposition, showcasing high potential for commercial usage. Another notable patent is "Anti-TIGIT antibodies and uses thereof." This patent discloses a novel antibody that specifically binds to the tumor-immunosuppressant TIGIT. It includes a comprehensive description of the antibody, its encoding nucleic acid, and its applications in cancer treatment, highlighting its significance in the pharmaceutical field.

Career Highlights

Throughout his career, Byung Hyun Choi has worked with reputable organizations such as Yuhan Corporation and Yonsei University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Ki Hong Kim and Moo Young Song. Their collaborative efforts have further advanced the research and development of innovative solutions in biotechnology.

Conclusion

Byung Hyun Choi's contributions to protein engineering and cancer treatment through his patents reflect his dedication to advancing scientific knowledge and improving healthcare solutions. His work continues to inspire future innovations in the field.